Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123123112 | 12312311 | 2 | F | 20160907 | 20160428 | 20160908 | EXP | CA-ROCHE-1748065 | ROCHE | 52.00 | YR | M | Y | 0.00000 | 20160908 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123123112 | 12312311 | 1 | PS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Subcutaneous | THERAPY DURATION: 20 DAYS | U | 103964 | |||||||||
123123112 | 12312311 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | U | 21511 | 1000 | MG | QD | |||||||
123123112 | 12312311 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | U | 21511 | 800 | MG | QD | |||||||
123123112 | 12312311 | 4 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | U | 21511 | 600 | MG | QD | |||||||
123123112 | 12312311 | 5 | SS | SOFOSBUVIR | SOFOSBUVIR | 1 | Oral | U | 0 | 400 | MG | QD | |||||||
123123112 | 12312311 | 6 | C | METHADONE | METHADONE HYDROCHLORIDE | 1 | Unknown | 0 | 9 | MG | |||||||||
123123112 | 12312311 | 7 | C | SALBUTAMOL | ALBUTEROL | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123123112 | 12312311 | 1 | Chronic hepatitis C |
123123112 | 12312311 | 2 | Chronic hepatitis C |
123123112 | 12312311 | 5 | Chronic hepatitis C |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123123112 | 12312311 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123123112 | 12312311 | Abnormal dreams | |
123123112 | 12312311 | Activities of daily living impaired | |
123123112 | 12312311 | Aggression | |
123123112 | 12312311 | Agitation | |
123123112 | 12312311 | Chest discomfort | |
123123112 | 12312311 | Depression | |
123123112 | 12312311 | Dizziness | |
123123112 | 12312311 | Drug intolerance | |
123123112 | 12312311 | Dysgeusia | |
123123112 | 12312311 | Dyspnoea | |
123123112 | 12312311 | Feeling abnormal | |
123123112 | 12312311 | Feeling hot | |
123123112 | 12312311 | Haemoglobin decreased | |
123123112 | 12312311 | Hepatic pain | |
123123112 | 12312311 | Homicidal ideation | |
123123112 | 12312311 | Hunger | |
123123112 | 12312311 | Insomnia | |
123123112 | 12312311 | Memory impairment | |
123123112 | 12312311 | Mood altered | |
123123112 | 12312311 | Mood swings | |
123123112 | 12312311 | Suicidal ideation | |
123123112 | 12312311 | Toothache |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |